Healthcare · Amsterdam
Vitalis
Remote cardiac monitoring that clinicians trust.
- Stage
- Series A
- Founded
- Founded 2020
- First invested
- We invested 2021
- Team
- 55 people
- Total raised
- $18M
- Current stage
- Series A
- Team
- 55
- Founded
- 2020
What they build
The product, in plain terms
Vitalis builds remote cardiac monitoring that clinicians trust. The company started in Amsterdam in 2020. We backed it at seed and have worked with the team through Series A.
- 01
Clinical workflows built with the people who use them, tested in a real setting before a single sales call.
- 02
Evidence generated on purpose. Studies, outcomes, published results, not testimonials.
- 03
Integrations with the record systems that already run the building, because nothing gets adopted beside them.
Where it stands
Numbers the team watches
Reported by the company at its most recent board meeting. We publish what founders are comfortable publishing and nothing more.
- Patients covered
- 6K
- Clinician retention
- 82%
- Time to first result
- 9 weeks
Why we invested
The note from the first meeting
“We met Vitalis in 2021, back when sales cycles ran in quarters and trust was the only thing that shortened them. What convinced us was not the deck. It was that they answered every hard question with a number and admitted the two they could not answer yet.”
- Went from prototype to paid pilot in a single quarter.
- Signed its first design partner before the program ended.
- Shipped the enterprise tier without hiring a single sales engineer.
Founders
Who is building it
Both founders were in the room the day we wrote the check, and both still run the company.
Rohan Chandra
Co-founder and CEO
Ran support for four years and knows the failure modes better than anyone selling against them.
Luca Ferreira
Co-founder and CTO
Spent four years on the infrastructure team this product replaces.
Timeline
How it has gone
The version we would give another investor, including the years where nothing looked like progress.
- 2020
Founded
Rohan Chandra and Luca Ferreira start Vitalis in Amsterdam around a single wedge: remote cardiac monitoring that clinicians trust.
- 2021
We invested
We wrote the seed check. Marcus Webb has worked with the team ever since.
- 2022
Paid customers
Contracts replaced pilots, and the company stopped selling a roadmap and started selling a product.
- 2023
Series A round
Raised at $110M, led by an investor we introduced during diligence. We took our full pro rata.
- 2026
Where it stands
55 people, selling in more markets than it started in, still run by the two people who wrote the first version.
Alongside us
Co-investors
We share rounds with people we would want on our own cap table.
- Kleiner Perkins
- Amplify Partners
- Foundation Capital
- Emergence
Working here
Open roles
Vitalis is hiring in these areas. Mention us and the note gets to the founders directly.
- Health system sales
- Clinical operations
- Regulatory
Building something next to Vitalis?
We are usually early to a category and happy to be early again. Send us the short version.